phenobarbital has been researched along with CJD (Creutzfeldt-Jakob Disease) in 2 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kikyo, H | 1 |
| Furukawa, T | 1 |
| Bücking, PH | 1 |
| Regli, F | 1 |
2 other studies available for phenobarbital and CJD (Creutzfeldt-Jakob Disease)
| Article | Year |
|---|---|
Creutzfeldt-Jakob-like syndrome induced by lithium, levomepromazine, and phenobarbitone.
Topics: Aged; Creutzfeldt-Jakob Syndrome; Electroencephalography; Female; Humans; Lithium; Male; Methotrimep | 1999 |
[The short periodicity of paroxysmal complex waves in electroencephalographic and clinical course of Creutzfeldt-Jakob disease (author's transl)].
Topics: Brain; Clonazepam; Creutzfeldt-Jakob Syndrome; Electroencephalography; Humans; Male; Middle Aged; Pe | 1979 |